Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 12-2019 | 12-2008 | |
| Sales | 44,097 | 0 | 13,302 | 0 | 3,707,000 |
| Cost of Goods | 23,700 | N/A | 1,769 | N/A | 505,000 |
| Gross Profit | 20,397 | N/A | 11,533 | N/A | 3,202,000 |
| Operating Expenses | 78,212 | 0 | 46,715 | 0 | 1,839,000 |
| Operating Income | -57,115 | N/A | -34,413 | N/A | 1,363,000 |
| Interest Expense | 475 | 0 | 592 | 0 | 24,000 |
| Other Income | -17,347 | 0 | 8,885 | 0 | 51,000 |
| Pre-tax Income | -74,937 | 0 | -26,120 | 0 | 1,390,000 |
| Income Tax | -159 | N/A | 6 | N/A | 459,000 |
| Net Income Continuous | -74,778 | N/A | -26,126 | N/A | 931,000 |
| Minority Interests | -1,209 | N/A | -71 | N/A | N/A |
| Net Income | $-73,569 | $N/A | $-26,055 | $N/A | $931,000 |
| EPS Basic Total Ops | -2.40 | N/A | -0.80 | N/A | 0.89 |
| EPS Basic Continuous Ops | -2.32 | N/A | -0.81 | N/A | 0.88 |
| EPS Diluted Total Ops | -2.40 | N/A | -0.80 | N/A | 0.88 |
| EPS Diluted Continuous Ops | -2.32 | N/A | -0.81 | N/A | 0.87 |
| EBITDA(a) | $-51,486 | $N/A | $-34,413 | $N/A | $1,522,000 |